License verification
Confirm issuing authority, license holder, site, scope, status, and product authorization.
Safety and quality
Trust should be supported by evidence.
Safety claims must connect to verified licenses, approved suppliers, product records, quality agreements, handling procedures, and attributable decisions.
Quality controls
Evidence before public claims or patient handoffs.
The following control categories define the intended model. A specific GDP, WDA(H), partner, source-region, carrier, or performance statement is publishable only when approved evidence supports it.
Traceability
Maintain product, supplier, batch, expiry, quantity, route, and handoff records appropriate to the case.
Handling control
Use approved storage, preparation, packaging, transport, deviation, and excursion procedures.
Human accountability
Keep eligibility, quality, release, exception, and escalation decisions attributable to authorized reviewers.
Applicable frameworks
Use the right framework for the right activity.
Regulatory names are not marketing badges. Their applicability depends on the entity, jurisdiction, activity, record, and supply-chain role.
EU GDP
Apply approved wholesale-distribution quality principles to relevant storage, transport, sourcing, documentation, complaints, returns, recalls, and outsourced activities.
FDA and CBP
FDA personal-importation guidance does not create a right to import. FDA and CBP retain inspection and admissibility authority.
GDPR and privacy
Define controller and processor roles, lawful bases, minimum necessary collection, rights, retention, transfers, and vendor safeguards.
GAMP 5 and Part 11
Apply risk-based validation and determine whether systems or records support regulated decisions. The public site must not become an uncontrolled regulated record channel.
Non-negotiable boundaries
What safety copy must never imply.
These statements remain visible across patient, employer, support, and resource content.
A category example is not an offer.
Patients identify requests with their clinicians; public copy does not steer selection or claim stock.
Regulated outcomes require accountable review.
Rules may flag completeness, but authorized people remain responsible for decisions.
Case review does not bind government authorities.
Inspection, detention, release, and refusal remain outside PharmaViaRx control.
General email and chat are not evidence channels.
Sensitive information moves only through approved, assessed, and access-controlled systems.
Need the full boundary?